The draft updated Nice guidance for ME/CFS highlights the unreliability of subjective outcome measures in non-blinded trials

Bibliographic Data

ID4227488
AuthorsMark Vink (0000-0003-1079-5647, Family and Insurance Physician, The Netherlands, corresponding author), Alexandra Vink-Niese (0000-0001-8018-1419, Independent researcher, Germany)
Year2022
Volume27
Issue1
Pages9-12
Publication date2022-01-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueJournal of Health Psychology (JOURNAL)
Journal identifiersISSN: 1359-1053 • E-ISSN: 1461-7277
PublisherSAGE Publications Inc (PUBLISHER)
DOI10.1177/1359105321990810
PMID33506707
OpenAlexW3123646151
LanguageEN
References cited12

The National Institute for Health and Care Excellence (NICE) recently published its draft updated guideline on the diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). NICE concluded that ME/CFS is a complex multisystem chronic medical condition for which graded exercise therapy should not be used and cognitive behavioural therapy is only a supportive therapy and not a treatment or cure. The draft guidance also highlighted the unreliability of subjective outcome measures in non-blinded trials. High quality randomised controlled ME/CFS trials are now needed to find pharmacological treatments that lead to substantial objective improvement and restore the ability to work

Chronic fatigue syndrome · Excellence · Guideline · Nice · Physical therapy · Fibromyalgia and Chronic Fatigue Syndrome Research · Health Systems, Economic Evaluations, Quality of Life · Medicine

Tools

Open DOI